193 related articles for article (PubMed ID: 7618437)
21. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophy.
Punkt K; Schering S; Löffler S; Minin EA; Samoilova VE; Hasselblatt M; Paulus W; Müller-Werdan U; Demus U; Koehler G; Boecker W; Buchwalow IB
Biochem Biophys Res Commun; 2006 Sep; 348(1):259-64. PubMed ID: 16876119
[TBL] [Abstract][Full Text] [Related]
23. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
Wang X; Xie Y; Zhang C; Liu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
[TBL] [Abstract][Full Text] [Related]
24. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
25. Creatine kinase, cell membrane and Duchenne muscular dystrophy.
Ozawa E; Hagiwara Y; Yoshida M
Mol Cell Biochem; 1999 Jan; 190(1-2):143-51. PubMed ID: 10098981
[TBL] [Abstract][Full Text] [Related]
26. Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD).
Reddy PA; Anandavalli TE; Anandaraj MP
Clin Chim Acta; 1986 Nov; 160(3):281-8. PubMed ID: 3024865
[TBL] [Abstract][Full Text] [Related]
27. Expression of three calpain isoform genes in human skeletal muscles.
Ueyama H; Kumamoto T; Fujimoto S; Murakami T; Tsuda T
J Neurol Sci; 1998 Mar; 155(2):163-9. PubMed ID: 9562261
[TBL] [Abstract][Full Text] [Related]
28. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.
Baghdiguian S; Martin M; Richard I; Pons F; Astier C; Bourg N; Hay RT; Chemaly R; Halaby G; Loiselet J; Anderson LV; Lopez de Munain A; Fardeau M; Mangeat P; Beckmann JS; Lefranc G
Nat Med; 1999 May; 5(5):503-11. PubMed ID: 10229226
[No Abstract] [Full Text] [Related]
29. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.
Baghdiguian S; Richard I; Martin M; Coopman P; Beckmann JS; Mangeat P; Lefranc G
J Mol Med (Berl); 2001 Jun; 79(5-6):254-61. PubMed ID: 11485017
[TBL] [Abstract][Full Text] [Related]
30. The calpain system in three muscles of normal and callipyge sheep.
Delgado EF; Geesink GH; Marchello JA; Goll DE; Koohmaraie M
J Anim Sci; 2001 Feb; 79(2):398-412. PubMed ID: 11219449
[TBL] [Abstract][Full Text] [Related]
31. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
[TBL] [Abstract][Full Text] [Related]
32. Leupeptin-based inhibitors do not improve the mdx phenotype.
Selsby J; Pendrak K; Zadel M; Tian Z; Pham J; Carver T; Acosta P; Barton E; Sweeney HL
Am J Physiol Regul Integr Comp Physiol; 2010 Nov; 299(5):R1192-201. PubMed ID: 20844259
[TBL] [Abstract][Full Text] [Related]
33. [Calpain and calpastatin].
Murachi T
Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
[TBL] [Abstract][Full Text] [Related]
34. Dystrophin expression in skin biopsy immunohistochemical. Localisation of striated muscle type dystrophin.
Marbini A; Marcello N; Bellanova MF; Guidetti D; Ferrari A; Gemignani F
J Neurol Sci; 1995 Mar; 129(1):29-33. PubMed ID: 7751841
[TBL] [Abstract][Full Text] [Related]
35. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical alterations of dystrophin in congenital muscular dystrophy.
Werneck LC; Bonilla E
Arq Neuropsiquiatr; 1995 Sep; 53(3-A):416-23. PubMed ID: 8540815
[TBL] [Abstract][Full Text] [Related]
37. Abnormal localization of laminin subunits in muscular dystrophies.
Hayashi YK; Engvall E; Arikawa-Hirasawa E; Goto K; Koga R; Nonaka I; Sugita H; Arahata K
J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011
[TBL] [Abstract][Full Text] [Related]
38. [A manifesting carrier of Duchenne muscular dystrophy presenting mosaic distribution of dystrophin negative and positive muscle fibers].
Kikumoto O; Yoshinaga J; Sasaki T; Ideshita H; Hikiji A; Arahata K
Rinsho Shinkeigaku; 1990 Jan; 30(1):107-9. PubMed ID: 2184962
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of dystrophin positive fibers in Duchenne muscular dystrophy].
Chuang YH; Jong YJ; Liu KM; Chen SS
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):409-15. PubMed ID: 7650780
[TBL] [Abstract][Full Text] [Related]
40. Postmortem proteolysis and calpain/calpastatin activity in callipyge and normal lamb biceps femoris during extended postmortem storage.
Geesink GH; Koohmaraie M
J Anim Sci; 1999 Jun; 77(6):1490-501. PubMed ID: 10375226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
